<DOC>
	<DOCNO>NCT01676467</DOCNO>
	<brief_summary>This study collect blood sputum ( phlegm ) sample subject asthma , smoker normal healthy subject , compare biological marker disease inflammation .</brief_summary>
	<brief_title>Sample Collection Smoking Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Inclusion Criteria ( healthy subject ) : Male female , 18 55 year age , inclusive . clinically significant abnormality . able produce adequate induce sputum sample . history chronic respiratory disease include asthma . history allergic symptom e.g. , allergic rhinitis , eczema . No acute illness 6 week prior Visit 1 . Additional Inclusion Criterion Healthy Smoking Subjects Be smoker &gt; /= 1 year . Additional Inclusion Criteria ( Persistent Asthmatic Subjects ) : No contraindication procedure study . Symptoms compatible asthma least 6 month prior screen Prebronchodilator FEV1 &gt; /=50 % predict Visit 1. clinically stable asthma least 6 week prior Visit 1 . No acute illness include asthma exacerbation require augmentation therapy 6 week prior Visit 1. current asthma controller therapy &gt; /= 6 week prior Visit 1 . Additional Inclusion Steroid Naïve Asthmatics ( smoke nonsmoking ) Must receive regular course inhale oral corticosteroid least 3 month prior Visit 1 . Additional Inclusion Smoking Asthmatics Be smoker &gt; /= 1 year prior Visit 1 . Exclusion Criteria ( healthy ) : History clinically significant medical illness medical disorder . Diagnosis chronic obstructive pulmonary disease ( COPD ) , cystic fibrosis , significant respiratory disorder include significant occupational environmental exposure ongoing respiratory symptom . bronchodilator response &gt; /=12 % least 200 mL baseline FEV1 value &lt; 85 % predict value Visit 1. positive urine pregnancy screen result . recent history ( within previous 6 month ) alcohol drug abuse . Positive urine toxicology screen substance abuse positive serology test HIV antibody , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( antiHCV ) Visit 1 . Received experimental antibody biologic therapy within 6 month prior Visit 1 , receive experimental therapy new investigational agent within 60 day Visit 1 . Is employee family member investigator , study centre Sponsor . Any condition , opinion investigator , would complicate compromise study , wellbeing subject . Use antioxidant within 1 week Visit 1 throughout study period . know allergy , hypersensitivity , intolerance short act βagonists ( SABA ) . Additional Exclusion Criterion Healthy Nonsmoking Subjects subject smoker ( regular irregular ) , smoke use nicotinecontaining product within 6 month prior Visit 1 . Additional Exclusion Criteria ( Persistent Asthma Subjects ) : Diagnosis allergic bronchopulmonary aspergillosis ( ABPA ) , allergic bronchopulmonary mycosis ( ABPM ) , occupational asthma . Diagnosis COPD , cystic fibrosis , significant respiratory disorder include significant occupational environmental exposure ongoing respiratory symptom . Use theophylline , Nacetyl cysteine , antioxidant within 1 week Visit 1 throughout study period . positive test tuberculosis Visit 1 . Additional Exclusion Criterion Nonsmoking Asthmatic Subjects subject smoker ( regular irregular ) , smoke use nicotinecontaining product within 6 month prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>